Werner Milton H.
SEC CIK 1827621 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | Pres, CEO, Dir, 10% | 5.34M | $61.5K | — | 6 | 2021-08-17 | 2022-08-16 |
Most active insiders at IKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SANDS FRANK M. | 10% | $3.00M | — |
| 2 | Cabell Christopher | Pres, Head of R, D | — | — |
| 3 | Aurentz Vincent | Dir | — | — |
| 4 | Munshi Amit | Dir | — | — |
| 5 | RA CAPITAL MANAGEMENT, L.P. | 10% | — | — |
| 6 | BERMAN DENNIS N | Dir | — | — |
Werner Milton H. made no open-market trades at IKT in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-16 | 2022-08-16 | IKT | Inhibikase Therapeutics, Inc. | Werner Milton H. | Pres, CEO, Dir, 10% | P - Purchase | $0.8 | +5,000 | 5.34M | +0.1% | +$4,000 | |
| 2022-05-31 | 2022-05-27 | IKT | Inhibikase Therapeutics, Inc. | Werner Milton H. | Pres, CEO, Dir, 10% | P - Purchase | $0.98 | +5,000 | 5.33M | +0.1% | +$4,900 | |
| 2022-05-23 | 2022-05-20 | IKT | Inhibikase Therapeutics, Inc. | Werner Milton H. | Pres, CEO, Dir, 10% | P - Purchase | $0.6 | +10.0K | 5.33M | +0.2% | +$6,000 | |
| D | 2022-01-04 | 2022-01-03 | IKT | Inhibikase Therapeutics, Inc. | Werner Milton H. | Pres, CEO, Dir, 10% | M - OptEx | $2.02 | +21.9K | 5.32M | +0.4% | +$44.1K |
| MI | 2021-11-19 | 2021-11-17 | IKT | Inhibikase Therapeutics, Inc. | Werner Milton H. | Pres, CEO, Dir, 10% | P - Purchase | $1.97 | +23.6K | 23.6K | New | +$46.6K |
| D | 2021-08-19 | 2021-08-17 | IKT | Inhibikase Therapeutics, Inc. | Werner Milton H. | Pres, CEO, Dir, 10% | M - OptEx | $2.02 | +21.9K | 5.29M | +0.4% | +$44.1K |
Purchase Sale Sale after option exercise All abbreviations